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Stenting of the iliac veins has been an established treatment for improving venous runoff from the legs after thrombolysis
of iliofemoral deep venous thrombosis for more than a decade, yet little is known about the long-term fate of stents in the
central veins. We describe a case of heavily calciﬁed in-stent restenosis in a 10-year-old venous stent as well as a way of
treating this rare condition. With growing numbers of venous stents reaching a signiﬁcant age, a need for treatment of
long-term complications like the one presented here most probably will arise. (J Vasc Surg Cases 2015;1:261-3.)Since the ﬁrst catheter-directed thrombolysis (CDT) of
thrombosed iliac veins described by Okrent et al1 in 1991,
the treatment has won widespread acceptance. Broholm
et al2 have shown that early CDT reduces the risk for devel-
opment of post-thrombotic syndrome, thus contributing
to the popularity of the treatment. Approximately half of
the cases treated with CDT are followed by stenting of
the iliac veins.3 Furthermore, stenting of the iliac veins is
a feasible way of relieving symptoms of established post-
thrombotic syndrome.4 However, by now, knowledge of
the long-term fate of venous stents is limited, yet the ﬁrst
reports of stent stenosis and occlusion and suggestions
for the treatment of such are beginning to appear in the
literature. With the ﬁrst stentings being far more than a
decade ago, long-term complications may be imminent,
leaving a need to establish treatments for late stent stenosis
and occlusions. In the following, we describe a case of
heavily calciﬁed in-stent restenosis that led to stent occlu-
sion, recently treated at our clinic. The patient has given
her consent for publication of the case.
CASE REPORT
The patient, a 35-year-old woman, was a nonsmoker and took
no oral contraceptives; she had a history of acute left-side iliofe-
moral deep venous thrombosis 10 years earlier. At the time, she
was treated with CDT and stenting of the left iliac veins. She
received warfarin for no more than 1 year despite the fact that
she was heterozygous for factor V Leiden mutation. In the past
10 years, she had given birth to two children.
She was referred to our clinic with 1 week’s recurrent symp-
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phlebography and color duplex ultrasound scan both showed
absence of ﬂow in the iliac stent. Outﬂow was partly re-
established after 1 day of ultrasound-accelerated CDT (UACDT),
but there was signiﬁcant residual thrombus. Because incomplete
thrombus resolution is not an uncommon ﬁnding after only
24 hours of UACDT, we continued the treatment, but the
thrombus showed no signs of further resolution even after an addi-
tional 2 days of UACDT. Digital subtraction phlebography
revealed severe compression of the stent (a 12-mm, 12-cm-long
nitinol stent) at the May-Thurner point, which did not seem to
be entirely covered by the stent, and residual thrombus inside
the stent distal to the compression. Anticipating the material to
be the rubbery chronic thrombus usually found in restenosed
stents, we decided to debulk the old stent to create sufﬁcient diam-
eter for a second stent to resolve the compression. Unfortunately,
mechanical debulking by that time was not yet standard treatment
at our center, so arrangements needed to be made to do the pro-
cedure. We therefore decided to treat the patient with provisional
plain balloon angioplasty at the site of compression preceded by
placement of a vena cava ﬁlter for protection against embolization
of thrombus material.
Mechanical debulking was planned to be performed 2 weeks
later, and she was discharged on high-dose low-molecular-weight
heparin.
DISCUSSION
Before debulking, we performed computed tomogra-
phy phlebography, which much to our surprise revealed se-
vere calciﬁcation of the material inside the stent, causing a
>75% stenosis distal to the compressed part of the stent
(Fig 1).
Since neither we nor our colleagues at the only other
center in Denmark performing interventions on the central
veins were familiar with calciﬁed in-stent restenosis in
venous stents, we searched the literature for this condi-
tion and suggestions on its treatment, but our search on
MEDLINE revealed no matching articles.
We decided to treat the patient as follows.
To eliminate any eventual fresh thrombus formed in
the 2-week waiting period, we started the procedure with
48 hours of UACDT with the EKOS EkoSonic system
(EKOS Corp, Bothell, Wash).
To create as big a lumen inside the old stent as possible,
we then performed transcatheter mechanical debulking261
Fig 1. Computed tomography scans showing compression of the stent at the May-Thurner point (a) and high-density
(calciﬁed) material inside the stent distal to the compression (b). Three-dimensional reconstructions of these scans
show the entire stent, including the compressed outﬂow and the calciﬁed material within it as well as the vena cava ﬁlter
(c and d).
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Medical AG, Wangs, Switzerland). The Rotarex catheter is
an over-the-wire device, consisting of a catheter with a
rotating head, spinning at 40,000 rpm, driven by an
external motor. The rotating head detaches and fragments
thrombus material from the vessel wall. An inner Archi-
medes screw inside the catheter, rotating at the same speed,
creates a vacuum that aspirates the material and transports
it out of the vessel. Although mechanical debulking of cal-
ciﬁcations is not strict on-label use of the Rotarex catheter,
it did remove some but far from all of the calciﬁed material
(visual estimate, 25%-50%; Fig 2).
After debulking, we preballooned the old stent with a
12-mm Atlas balloon (C. R. Bard Inc, Murray Hill, NJ),
a noncompliant high-pressure balloon, at 16 bar, forcing
the residual material into the vessel wall.
The lesion was then restented with a 12-mm, 15-cm
sinus-Venous stent (Optimed GmbH, Ettlingen, Ger-
many), a dedicated venous stent with a high radial force,
covering the entire May-Thurner compression and the
entire length of the previous stent, thus sandwiching the
material between the two stents. The entire stent complexwas then postballooned with a 12-mm Atlas balloon at
14 bar to pack the sandwiched material as much as possible
and to resolve the May-Thurner compression, thus
restoring unobstructed outﬂow from the leg.
Final four-plane digital subtraction phlebography
showed the new stent fully expanded, the May-Thurner
compression completely resolved, and the residual material
sandwiched between the stents (Fig 3). The cava ﬁlter was
shown to be free of emboli and was removed at the end of
the procedure. The patient experienced instant relief of
symptoms and was discharged the following day on lifelong
warfarin, 14 days of high-dose low-molecular-weight hep-
arin, and 1 year with compression stockings.
On the ﬁrst follow-up visits 6 weeks and 3 months after
the procedure, she was asymptomatic, and duplex ultra-
sound showed normal ﬂow in the deep veins including
the stented area. Further follow-up visits are planned at
6, 9, 12, 18, and 24 months after the procedure.
CONCLUSIONS
With rising numbers of venous stents reaching a signif-
icant age, the number of late complications, such as stent
Fig 2. Digital subtraction phlebography showing the results after
48 hours of ultrasound-accelerated catheter-directed thrombolysis
(UACDT, a) and after mechanical debulking with the Rotarex
catheter (b).
Fig 3. Digital subtraction phlebography in the anteroposterior
projection (a) and at the same angle of view as the three-
dimensional reconstruction in Fig 1, c (b) showing the re-
established venous outﬂow through the left iliac veins. The new
stent is fully expanded and covers the entire length of the old stent,
including the May-Thurner point. The residual calciﬁed material is
sandwiched between the two stents on the inferior right-hand side.
JOURNAL OF VASCULAR SURGERY CASES
Volume 1, Number 4 Schmidt et al 263restenosis and occlusion, may increase in the following
years. Stent primary patency rates for stented chronic
venous lesions are reported to be in the range of 57% to
79% at 72 months.5 Suggestions for treatment of in-stent
restenosis and occlusion range from CDT with or without
restenting to more technically advanced solutions, like
percutaneous or open thrombectomy with or without
restenting.
We here describe calciﬁed in-stent restenosis as a rare
late stent-related complication and show a feasible, mini-
mally invasive, and supposedly safe way of treating the
condition.
The large time span from initial treatment to occur-
rence of late complication in our case (10 years) indicates
that prolonged stent surveillance may be indicated to
detect restenosis before it leads to stent occlusion. At least
this could be of beneﬁt for individuals at risk (ie, for indi-
viduals with thrombophilia, after pregnancies, and for indi-
viduals with suboptimal initial treatment). More data on
long-term follow-up of venous stents will be helpful in esti-
mating the extent of the problem.We are deeply grateful to Dr Gerard O’Sullivan, Uni-
versity Hospital Galway, Ireland, for his swift and kind
advice on this challenging case.REFERENCES
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